We're a Registered Charity Organization in Tanzania
Ifakara Health Institute (IHI) is officially recognized as a charitable organization under the Income Tax Act.
Certification issued on 20 March 2025 and valid until 31 December 2030.
@70Principal Investigator: Dr. Samuel Salvatory
Project leader/ Coordinator: PD Dr. Med Thomas Zoller
Project Administrator: TBC
Funding Partner: Charite University Hospital
Start date: Feb. 1, 2026
End date: July 31, 2027
The AFROCAP-PILOT study, led by the Ifakara Health Institute, marks a significant step in advancing research on community-acquired pneumonia (CAP) among adults in sub-Saharan Africa. It seeks to generate critical evidence to improve the diagnosis, treatment, and overall management of pneumonia across the region.
Community-acquired pneumonia remains a leading cause of illness and death globally. However, while high-income countries have robust data systems, sub-Saharan Africa still faces a shortage of comprehensive, standardized data on adult pneumonia cases.
Mortality rates in the region are significantly higher, yet most available studies are limited to small, single-center investigations. AFROCAP seeks to change this by laying the groundwork for a large-scale, multi-country research network focused on pneumonia.
The AFROCAP pilot aims to:
The study will also evaluate operational aspects such as patient recruitment, data collection quality, and feasibility of implementing standardized research systems across multiple settings.
The research will be conducted at St. Francis Regional Referral Hospital in Tanzania and will enroll approximately 300 adult participants, including, 200 patients with confirmed pneumonia and 100 patients with tuberculosis presenting similar symptoms
Beyond research, AFROCAP is expected to strengthen healthcare systems by:
The study is supported by Charité – Universitätsmedizin Berlin and brings together a multidisciplinary team of local and international researchers.
As a pilot initiative, AFROCAP is expected to inform the development of a future multi-country, multi-center research network across Africa. By generating high-quality data and testing standardized methodologies, the project will help shape more effective responses to pneumonia and related diseases across the continent.